The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease

Saved in:
Bibliographic Details
Published inProtein & cell Vol. 4; no. 4; pp. 248 - 250
Main Authors Ren, Zhilin, Yan, Liming, Zhang, Ning, Guo, Yu, Yang, Cheng, Lou, Zhiyong, Rao, Zihe
Format Journal Article
LanguageEnglish
Published Beijing Higher Education Press 01.04.2013
Springer Nature B.V
Subjects
Binding Sites
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cysteine Endopeptidases - metabolism
Developmental Biology
Human Genetics
Humans
Isoxazoles - chemistry
Isoxazoles - pharmacology
Life Sciences
Perspective
Protease Inhibitors - chemistry
Protease Inhibitors - metabolism
Protease Inhibitors - pharmacology
Protein Science
Protein Structure, Tertiary
Pyrrolidinones - chemistry
Pyrrolidinones - pharmacology
Rhinovirus - drug effects
SARS Virus - drug effects
SARS Virus - enzymology
Severe Acute Respiratory Syndrome - virology
Stem Cells
Viral Proteins - antagonists & inhibitors
Viral Proteins - metabolism
Severe Acute Respiratory Syndrome
Substrate Binding Site
Colored Stick
Main Protease
Severe Acute Respiratory Syndrome Virus
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1674-800X
1674-8018
DOI:10.1007/s13238-013-2841-3